StockData
Repligen Corp logo

Repligen Corp (RGEN) stock

RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/30133% above fair value
$162.18−0.60 (-0.37%)

Close on Nov 17, 2026Market cap $10.37BP/E –Yield –

Repligen operating margin

Operating margin is operating income as a percentage of revenue.

Repligen's operating margin for the twelve months ending Sep 30, 2026 was 2.3%. For fiscal 2025 it was 7.5%, against -5.5% the year before. The highest annual figure on record is 33.6% in fiscal 2013.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20257.5%+13.0
FY2024Dec 31, 2024-5.5%−13.1
FY2023Dec 31, 20237.5%−20.5
FY2022Dec 31, 202228.0%+3.1
FY2021Dec 31, 202124.9%+5.9
FY2020Dec 31, 202019.1%+5.7
FY2019Dec 31, 201913.4%−0.0
FY2018Dec 31, 201813.4%+3.5
FY2017Dec 31, 20179.9%−5.4
FY2016Dec 31, 201615.3%−1.2
FY2015Dec 31, 201516.5%−0.3
FY2014Dec 31, 201416.8%−16.7
FY2013Dec 31, 201333.6%+34.9
FY2011Mar 31, 2011-1.4%+26.1
FY2010Mar 31, 2010-27.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-14.1%−23.0
Q2 FY2026Jun 30, 20266.8%−0.8
Q1 FY2026Mar 31, 20268.2%+4.3
Q4 FY2025Dec 31, 20259.0%+30.8
Q3 FY2025Sep 30, 20258.9%+14.0
Q2 FY2025Jun 30, 20257.6%+4.2
Q1 FY2025Mar 31, 20253.9%+1.4
Q4 FY2024Dec 31, 2024-21.8%−27.7
Q3 FY2024Sep 30, 2024-5.1%−8.4
Q2 FY2024Jun 30, 20243.4%−8.7
Q1 FY2024Mar 31, 20242.4%−5.9
Q4 FY2023Dec 31, 20235.9%−20.2
Q3 FY2023Sep 30, 20233.3%−22.9
Q2 FY2023Jun 30, 202312.1%−18.3
Q1 FY2023Mar 31, 20238.4%−20.7
Q4 FY2022Dec 31, 202226.1%+6.1
Q3 FY2022Sep 30, 202226.2%+0.9
Q2 FY2022Jun 30, 202230.4%+0.8
Q1 FY2022Mar 31, 202229.1%+3.6
Q4 FY2021Dec 31, 202120.1%+4.0
Q3 FY2021Sep 30, 202125.4%+3.1
Q2 FY2021Jun 30, 202129.6%+7.3
Q1 FY2021Mar 31, 202125.5%+9.8
Q4 FY2020Dec 31, 202016.0%+7.5
Q3 FY2020Sep 30, 202022.3%+10.8
Q2 FY2020Jun 30, 202022.3%+6.7
Q1 FY2020Mar 31, 202015.6%−2.8
Q4 FY2019Dec 31, 20198.5%−6.6
Q3 FY2019Sep 30, 201911.5%−4.5
Q2 FY2019Jun 30, 201915.6%+6.7
Q1 FY2019Mar 31, 201918.4%+5.1
Q4 FY2018Dec 31, 201815.1%+7.3
Q3 FY2018Sep 30, 201815.9%+17.0
Q2 FY2018Jun 30, 20189.0%−7.9
Q1 FY2018Mar 31, 201813.3%−5.2
Q4 FY2017Dec 31, 20177.8%−3.5
Q3 FY2017Sep 30, 2017-1.1%–
Q2 FY2017Jun 30, 201716.9%–
Q1 FY2017Mar 31, 201718.6%–
Q4 FY2016Dec 31, 201611.3%–

More Repligen figures

See a number that looks wrong?